Acer Therapeutics Inc
ACER
ACER was delisted on the 8th of November, 2023.
18 hedge funds and large institutions have $2.31M invested in Acer Therapeutics Inc in 2014 Q1 according to their latest regulatory filings, with 4 funds opening new positions, 5 increasing their positions, 3 reducing their positions, and 4 closing their positions.
67% more repeat investments, than reductions
Existing positions increased: 5 | Existing positions reduced: 3
18% more capital invested
Capital invested by funds: $1.96M → $2.31M (+$349K)
0% more funds holding
Funds holding: 18 → 18 (0)
0% more first-time investments, than exits
New positions opened: 4 | Existing positions closed: 4
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
+$761K |
| 2 |
Morgan Stanley
New York
|
+$90.4K |
| 3 |
SKK
Shepherd Kaplan Krochuk
Boston,
Massachusetts
|
+$40.1K |
| 4 |
CS
Credit Suisse
Zurich,
Switzerland
|
+$25.5K |
| 5 |
GC
Guggenheim Capital
Chicago,
Illinois
|
+$20.5K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SC
Sophrosyne Capital
New York
|
-$366K |
| 2 |
VKH
Virtu KCG Holdings
New York
|
-$99.7K |
| 3 |
SIM
Spark Investment Management
New York
|
-$68K |
| 4 |
TRCT
Tower Research Capital (TRC)
New York
|
-$44.9K |
| 5 |
Wells Fargo
San Francisco,
California
|
-$29K |
ACER Hedge Fund Activity: Q1 2014 in Review
18 of the 3,463 institutional investors tracked by Wall St. Rank reported a position in Acer Therapeutics Inc (ACER) for Q1 2014, worth a combined $2.31M — up 18% from $1.96M a quarter earlier.
Fund positioning in ACER was balanced in Q1 2014: 4 funds opened new positions, 4 closed out, 5 added to existing stakes and 3 trimmed.
The largest buyer was Vanguard Group, adding an estimated $761K. The largest seller was Sophrosyne Capital, exiting entirely with an estimated $366K sold.
- 18 institutional investors held Acer Therapeutics Inc (ACER) as of Q1 2014, unchanged from Q4 2013.
- Funds reported $2.31M of Acer Therapeutics Inc stock for Q1 2014, up 18% quarter-over-quarter.
- 4 funds opened new Acer Therapeutics Inc positions in Q1 2014 and 4 closed out, a net change of 0 holders.
- The largest Acer Therapeutics Inc buyer in Q1 2014 was Vanguard Group, an estimated $761K added.
- The largest Acer Therapeutics Inc seller in Q1 2014 was Sophrosyne Capital, an estimated $366K sold.
Based on aggregated 13F filings for Q1 2014.